Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Blank

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Frontiers in Allergy|September 29, 2022
Role of microRNAs in type 2 diseases and allergen-specific immunotherapyConstanze A Jakwerth, Hannah Kitzberger, Dimitrii Pogorelov, et al.
The Journal of Allergy and Clinical Immunology|March 29, 2011
Detection of IgE to recombinant Api m 1 and rVes v 5 is valuable but not sufficient to distinguish bee from wasp venom allergyGunter J Sturm, Wolfgang Hemmer, Thomas Hawranek, et al.
The Journal of Allergy and Clinical Immunology|January 21, 2014
Component resolution reveals additional major allergens in patients with honeybee venom allergyJulian Köhler, Simon Blank, Sabine Müller, et al.
Current Allergy and Asthma Reports|July 11, 2020
Antigen 5 Allergens of Hymenoptera Venoms and Their Role in Diagnosis and Therapy of Venom AllergySimon Blank, Murilo Luiz Bazon, Johannes Grosch, et al.
Molecular Immunology|April 9, 2011
Generation and epitope analysis of human monoclonal antibody isotypes with specificity for the Timothy grass major allergen Phl p 5aJulia Hecker, Andrea Diethers, Stefanie Etzold, et al.
Protein and Peptide Letters|December 22, 2010
Evaluation of different glycoforms of honeybee venom major allergen phospholipase A2 (Api m 1) produced in insect cellsSimon Blank, Yvonne Michel, Henning Seismann, et al.
The Journal of Allergy and Clinical Immunology|December 3, 2013
Identification of Hymenoptera venom-allergic patients with negative specific IgE to venom extract by using recombinant allergensLiliana Cifuentes, Sebastian Vosseler, Simon Blank, et al.
Allergy|December 21, 2020
Comprehensive mapping of immune tolerance yields a regulatory TNF receptor 2 signature in a murine model of successful Fel d 1-specific immunotherapy using high-dose CpG adjuvantCathy Leonard, Guillem Montamat, Caroline Davril, et al.
Human Vaccines & Immunotherapeutics|May 12, 2017
Component-resolved evaluation of the content of major allergens in therapeutic extracts for specific immunotherapy of honeybee venom allergySimon Blank, Stefanie Etzold, Ulf Darsow, et al.
Molecular Immunology|December 3, 2014
IgE recognition of chimeric isoforms of the honeybee (Apis mellifera) venom allergen Api m 10 evaluated by protein array technologyMatthias Van Vaerenbergh, Lina De Smet, David Rafei-Shamsabadi, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Frontiers in Allergy|September 29, 2022
Role of microRNAs in type 2 diseases and allergen-specific immunotherapyConstanze A Jakwerth, Hannah Kitzberger, Dimitrii Pogorelov, et al.
The Journal of Allergy and Clinical Immunology|March 29, 2011
Detection of IgE to recombinant Api m 1 and rVes v 5 is valuable but not sufficient to distinguish bee from wasp venom allergyGunter J Sturm, Wolfgang Hemmer, Thomas Hawranek, et al.
The Journal of Allergy and Clinical Immunology|January 21, 2014
Component resolution reveals additional major allergens in patients with honeybee venom allergyJulian Köhler, Simon Blank, Sabine Müller, et al.
Current Allergy and Asthma Reports|July 11, 2020
Antigen 5 Allergens of Hymenoptera Venoms and Their Role in Diagnosis and Therapy of Venom AllergySimon Blank, Murilo Luiz Bazon, Johannes Grosch, et al.
Molecular Immunology|April 9, 2011
Generation and epitope analysis of human monoclonal antibody isotypes with specificity for the Timothy grass major allergen Phl p 5aJulia Hecker, Andrea Diethers, Stefanie Etzold, et al.
Protein and Peptide Letters|December 22, 2010
Evaluation of different glycoforms of honeybee venom major allergen phospholipase A2 (Api m 1) produced in insect cellsSimon Blank, Yvonne Michel, Henning Seismann, et al.
The Journal of Allergy and Clinical Immunology|December 3, 2013
Identification of Hymenoptera venom-allergic patients with negative specific IgE to venom extract by using recombinant allergensLiliana Cifuentes, Sebastian Vosseler, Simon Blank, et al.
Allergy|December 21, 2020
Comprehensive mapping of immune tolerance yields a regulatory TNF receptor 2 signature in a murine model of successful Fel d 1-specific immunotherapy using high-dose CpG adjuvantCathy Leonard, Guillem Montamat, Caroline Davril, et al.
Human Vaccines & Immunotherapeutics|May 12, 2017
Component-resolved evaluation of the content of major allergens in therapeutic extracts for specific immunotherapy of honeybee venom allergySimon Blank, Stefanie Etzold, Ulf Darsow, et al.
Molecular Immunology|December 3, 2014
IgE recognition of chimeric isoforms of the honeybee (Apis mellifera) venom allergen Api m 10 evaluated by protein array technologyMatthias Van Vaerenbergh, Lina De Smet, David Rafei-Shamsabadi, et al.
Pageof 7